European Pharmacoepidemiology & Pharmacovigilance Research Network (EU PE&PV) was initiated in 2015 and coordinated by the Division of Pharmacoepidemiology & Clinical Pharmacology at the Utrecht Institute for Pharmaceutical Sciences (Utrecht University). This research network encompasses a consortium of 27 research institutions working on RWE projects across Europe. EU PE&PV strives to conduct high quality pharmacopeidemiology and pharmacovigilance research across various therapeutic areas.
VAC4EU has collaborated with EUPE&PV on various EMA-funded projects throughout the last five years including:
EMA Early COVID-19 Vaccine Monitor (ECVM): Cohort Event Monitoring of Safety of COVID-19 Vaccines (Early-) Covid-Vaccine-Monitor
COVID Vaccines Effectiveness (CoVE): Effectiveness of Heterologous and Booster COVID-19 Vaccination in 5 European Countries, Using a Cohort Approach in Children and Adults with a Full Primary Vaccination Regimen
EMA COVID-19 Vaccine Monitor (CVM): Rapid Safety Assessment of SARS-CoV-2 Vaccines in EU Member States Using Electronic Health Care Datasources
VACcine Covid-19 monitoring readinESS (ACCESS)
EMA SAFETY-VAC: A Framework for the Post-Authorisation Safety Evaluation of Vaccines in the Europe
Back to collaborations